Completed PHASE3 INTERVENTIONAL 2-arm NCT01422811

Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation

Sponsor: Azienda Ospedaliero-Universitaria di Parma

Conditions Hospitalization Length of Stay

Interventions Multicomponent strategy to reduce avoidable length of stay No intervention

Updated 5 times since 2017 Last updated: Jul 2, 2018 Started: Feb 29, 2008 Primary completion: Feb 28, 2009 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hospitalization and Length of Stay, this trial is completed. The trial is conducted by Azienda Ospedaliero-Universitaria di Parma and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Aug 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Aug 2018 [monthly]

Completed PHASE3

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliero-Universitaria di Parma
Regione Emilia-Romagna

Data source: Azienda Ospedaliero-Universitaria di Parma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Parma, Italy